Skip to content

Investigating the effect of direct electrical stimulation of the brain in improving anxiety, depression, quality of life and severity of symptoms in patients with irritable bowel syndrome

The effect of trans cranial direct current stimulation (TDCS) intervention on improving anxiety, depression, quality of life, and severity of symptom in patients with moderate to severe irritable bowel syndrome under treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220727055566N1
Enrollment
40
Registered
2022-12-20
Start date
2022-10-22
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Irritable Bowel Syndrome (IBS). Condition 2: Irritable Bowel Syndrome (IBS). Condition 3: Irritable Bowel Syndrome (IBS). Irritable bowel syndrome with mixed bowel habits [IBS-M] Irritable bowel syndrome with predominant diarrhoea [IBS-D] Irritable bowel syndrome with predominant constipation [IBS-C]

Interventions

Intervention 1: Intervention group: The intervention group is treated with electrical stimulation of the brain. The anode of the device is placed at the F3 place on the skull and the cathode is placed

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Men and women aged 18 to 65 years Diagnosis of moderate and severe IBS disorder based on ROME III criteria by gastroenterologist Informed consent to participate in the study Having at least reading and writing literacy Living in the city of Isfahan

Exclusion criteria

Exclusion criteria: Diagnosing any organic disease during the study that makes it impossible to continue participating in the study. Failure to visit on time to complete the treatment process Intolerance of the patient to therapy Willingness to withdraw from the study for any reason The existence of serious suicidal thoughts or plans Pregnancy or breastfeeding Substance use History of seizures Having a pacemaker Taking antidepressants and anti-anxiety drugs from 2 weeks ago

Design outcomes

Primary

MeasureTime frame
Stress score in Depression, Anxiety and Stress Scale questionnaire. Timepoint: Stress scores are measured before the start of the intervention, 5 days and 30 days after the start of the intervention. Method of measurement: Depression, Anxiety and Stress Scale is a 21-question self-report questionnaire that is a set of 3 scales designed with 14 questions to measure negative emotional states in depression, anxiety and stress.;Irritable bowel syndrome symptom severity score in irritable bowel severity scoring system questionnaire. Timepoint: The time periods of measuring the severity score of irritable bowel syndrome symptoms are done before the intervention, 5 days and 30 days after the intervention. Method of measurement: The Irritable Bowel Severity Scoring System is a self-report questionnaire consisting of 5 sections that measures the severity of symptoms of irritable bowel syndrome, including pain, defecation disorder, bloating, the effect of the disease on daily life activities, and extraintestinal symptoms with a scale. Visual Analog Scale checks.;Score of quality of life in Irritable Bowel Syndrome - Quality of Life questionnaire. Timepoint: The time periods for measuring the quality of life score in irritable bowel syndrome disease are performed before the intervention, 5 days and 30 days after the intervention. Method of measurement: The quality of life questionnaire for irritable bowel syndrome is a self-administered questionnaire with 34 questions that examines various aspects of the quality of life of people with irritable bowel syndrome.;Depression score in Depression, Anxiety and Stress Scale questionnaire. Timepoint: Depression scores are measured before the start of the intervention, 5 days and 30 days after the start of the intervention. Method of measurement: Depression, Anxiety and Stress Scale is a 21-question self-report questionnaire that is a set of 3 scales designed with 14 questions to measure negative emotional states in depression, anxiety

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaedeh Rezaei Koujani

Esfahan University of Medical Sciences

maedeh.rezaei48@gmail.com+98 31 3421 5356

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026